Thorofare, NJ – Vindico Medical Education, a Wyanoke Group company, is pleased to announce the presentation of accepted poster “The Impact of Serial Learning on Clinician Comfort and Use of Second-Generation Anti-VEGF Agents,” authored by Charlene Depry, PhD; Katie Robinson, PhD, CHCP; Kevin Lester; Simon Cooper, PhD; Sasha Persaud, PharmD, and Rishi Singh, MD, at the 2026 Retina World Congress.

The Retina World Congress brings together more than 1000 physicians, health care professionals, and industry participants to redefine innovations and impact of retina care on a global scale. This year’s meeting will be held May 14-17, 2026, in Fort Lauderdale, Florida. retinaworldcongress.org

The poster highlights how curriculum-based continuing education can enhance clinician performance in the evolving landscape of second-generation anti-VEGF therapies. Specifically, it details the outcomes of Retina Master Class—a multimodal, 14-part CME program designed to improve knowledge, confidence, and clinical decision-making among ophthalmologists who treat patients with retinal disorders—supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Charlene Depry, PhD, Director, Instructional Design and Analytics, Vindico Medical Education, will present the poster during designated poster viewing hours in Fort Lauderdale.

To view the poster, please visit this link.

For more information regarding Vindico’s poster, contact Charlene Depry, PhD.